Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied

scientific article

Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID76453

P2093author name stringSnider GL
O'Brien JJ
Goldstein RH
Celli BR
Lucey EC
P433issue2
P921main subjectcarbon monoxideQ2025
pulmonary fibrosisQ32446
P304page(s)289-297
P577publication date1978-02-01
P1433published inThe American Review of Respiratory DiseaseQ26839505
P1476titleChronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied
P478volume117

Reverse relations

cites work (P2860)
Q37664164A mouse model of chronic idiopathic pulmonary fibrosis
Q53763737Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9.
Q35819150Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence
Q41751872Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation
Q33840511Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells
Q39525128Bleomycin-induced lung injury in baboons: Alteration of cells and immunoglobulins recoverable by bronchoalveolar lavage
Q39541916Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin
Q41967080Bleomycin-stimulated hamster alveolar macrophages release interleukin-1.
Q35836499Capillary remodeling in bleomycin-induced pulmonary fibrosis
Q41908752Changes in distribution, morphology, and tumor necrosis factor-alpha secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis
Q72715663Chronic airway obstruction and bronchiectasis in the rat after intratracheal bleomycin
Q41127857Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats
Q35070654Direct leukocyte migration across pulmonary arterioles and venules into the perivascular interstitium of murine lungs during bleomycin injury and repair
Q46726026Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury.
Q36287478Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice
Q30705373Effects of a calmodulin inhibitor on bleomycin-induced lung inflammation in hamsters. Biochemical, morphometric, and bronchoalveolar lavage data
Q36227450Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis
Q50351279Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice.
Q45047357Lung lymphocytes in bleomycin-induced pulmonary disease
Q37543830Lung parenchymal mechanics in health and disease
Q36356735Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation
Q38610456Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades
Q49603082Modeling Idiopathic Pulmonary Fibrosis in Humanized SCID Mice.
Q35858455Modulation of bleomycin-induced pulmonary fibrosis in the BALB/c mouse by cyclophosphamide-sensitive T cells
Q35885653Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters.
Q46210414Prevention of bleomycin-induced fibrosing alveolitis with indomethacin: Stereological studies on rat lungs
Q34563633Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis
Q35034650Pulmonary function testing in small laboratory mammals
Q34183326Radiation effects in the lung
Q35533319Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters
Q67531268Superoxide anion production by rat neutrophils at various stages of bleomycin-induced lung injury
Q37346515The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance
Q36970923The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Q40103779The correlation of lung structure with function
Q42735294The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats
Q35885084The effect of alpha-difluoromethylornithine on the development of bleomycin-induced pulmonary fibrosis in hamsters.
Q41837635The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis.
Q41891748The role of soluble factors in bleomycin-induced pulmonary fibrosis
Q34186283Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis
Q44181987Time course of bleomycin-induced lung fibrosis.
Q46573924gamma-Linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters
Q42734045β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix

Search more.